1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. ASTRAZENECA PLC - ADR
Astrazeneca plc - ADR XNAS: AZN

Astrazeneca plc - ADR Live Stock Price Today, Share Analysis and Chart

Turnaround Potential
about

A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (about 40% of total revenue), cardiovascular, renal, and m...

Read More
81.70 -0.08 (-0.10%)
Near 52W High of $83.43
2.5M
XNAS Volume

XNAS 05 Sep, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Alert

Share
Board Meeting
The next board meeting for Astrazeneca plc - ADR is on 15 Sep 2025 for the purpose of Bus Tour, UBS Pharma Bus Tour, Virtual [Management] 2025 See details
Durability score
Medium Financial Strength
50.0 / 100
Valuation Score
Mid Valuation
32.0 / 100
Momentum Score
Technically Moderately Bullish
64.3 / 100
Turnaround Potential These stocks may be affordable or expensive due to their medium quality and a good technical scoring. However, their reasonable financials successfully attract investors. View Similar Embed DVM
Analyst Price Target
87
1Yr Price target upside is 7%
10 analysts

17

S

6

W

1

O

2

T

SWOT Analysis

Astrazeneca plc ADR Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..